Geode Capital Management, LLC Alkermes Plc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 3,873,927 shares of ALKS stock, worth $117 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,873,927
Previous 3,933,964
1.53%
Holding current value
$117 Million
Previous $94.8 Million
14.37%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding ALKS
# of Institutions
360Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$876 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$571 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$391 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$381 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$276 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.94B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...